AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 DEC 2 - (NewsRx.com & NewsRx.net) -- Ovarian hyperandrogenism associated with luteal insufficiency increases the premenopausal women's risk of developing breast cancer, researchers in Italy report.
"Because of large intra-individual variation in hormone levels, few studies have investigated the relation of serum sex hormones to breast cancer (BC) in premenopausal women. We prospectively studied this relation, adjusting for timing of blood sampling within menstrual cycle," said A. Micheli and colleagues.
"Premenopausal women (n=5,963), recruited to the Hormones and Diet in the Etiology of Breast Tumors (ORDET) cohort study, provided a blood sample in the 20-24th day of their menstrual cycle. After 5.2 years of follow-up, 65 histologically confirmed BC cases were identified and matched individually to four randomly selected controls," the researchers said.
They had levels of the following hormones measured blindly from serum samples stored at -80 degrees C: for dehydroepiandrosterone sulfate; total and free testosterone (FT); androstenedione; androstanediol-glucoronide; progesterone; 17-OH-progesterone; sex hormone-binding globulin; follicle-stimulating hormone (FSH); and luteinizing hormone (LH).
Multivariate analyses could be performed on 55 of the 65 cases.
"Compared to controls, BC cases had shorter cycles and intervals between blood sampling and bleeding, and lower LH and FSH," according to the report.
Micheli and colleagues found "FT was significantly ...
Source: HighBeam Research, Serum sex hormones associated with increased cancer risk in younger...